Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Asia Pacific (Supplemental) | 2014 | Market Analysis

The Asia Pacific heart valve device market will experience robust growth through 2022, driven by economic growth, an aging population, and the adoption of THV devices.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the heart valve device market in Asia Pacific, including country-level data for 13 major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Related Medtech Insights Reports

Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Sports Medicine Devices – Market Insights – Asia Pacific
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, and improved surgeon training will drive rapid growth in the Asia Pacific…
Report
Aesthetic Injectables – Market Insights – Asia Pacific
The Asia Pacific aesthetic injectable market will continue to expand through 2034, fueled by continuous innovation and the introduction of differentiated products by leading global and regional…